JGC
J. Goldman & Co’s Axsome Therapeutics AXSM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14M | Buy |
39,655
+37,359
| +1,627% | +$3.9M | 0.1% | 163 |
|
|
2025
Q1 | $268K | Sell |
2,296
-38,027
| -94% | -$4.44M | 0.01% | 278 |
|
|
2024
Q4 | $3.41M | Buy |
40,323
+32,044
| +387% | +$2.71M | 0.09% | 173 |
|
|
2024
Q3 | $744K | Sell |
8,279
-57
| -0.7% | -$5.12K | 0.02% | 220 |
|
|
2024
Q2 | $671K | Sell |
8,336
-560
| -6% | -$45.1K | 0.02% | 235 |
|
|
2024
Q1 | $710K | Buy |
8,896
+3,341
| +60% | +$267K | 0.02% | 202 |
|
|
2023
Q4 | $442K | Sell |
5,555
-48,256
| -90% | -$3.84M | 0.02% | 174 |
|
|
2023
Q3 | $3.76M | Buy |
53,811
+37,865
| +237% | +$2.65M | 0.13% | 104 |
|
|
2023
Q2 | $1.15M | Sell |
15,946
-46,405
| -74% | -$3.33M | 0.04% | 158 |
|
|
2023
Q1 | $3.85M | Buy |
62,351
+59,652
| +2,210% | +$3.68M | 0.16% | 116 |
|
|
2022
Q4 | $208K | Buy |
+2,699
| New | +$208K | 0.01% | 235 |
|
|
2020
Q1 | – | Sell |
-3,753
| Closed | -$388K | – | 183 |
|
|
2019
Q4 | $388K | Sell |
3,753
-7,624
| -67% | -$788K | 0.03% | 150 |
|
|
2019
Q3 | $230K | Buy |
11,377
+1,699
| +18% | +$34.3K | 0.02% | 155 |
|
|
2019
Q2 | $249K | Sell |
9,678
-37,295
| -79% | -$960K | 0.02% | 151 |
|
|
2019
Q1 | $668K | Buy |
+46,973
| New | +$668K | 0.04% | 134 |
|